Aenova set to allocate, OID kept at 99
The €297.5m of leveraged loans backing BC Partners’ buyout of German pharmaceutical company Aenova will be allocated to investors on Friday after the deal received a "solid" response from investors, according to a banker close to the deal.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: